Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics
MOUNTAIN VIEW, Calif. -- Aditxt, Inc. (“Aditxt” or “the Company”) (NASDAQ: ADTX), an innovation platform dedicated to discovering, developing, and deploying promising health innovations, today announced that it had entered into a third amending agreement with Appili Therapeutics, Inc. (TSX: APLI; OTCPink: APLIF) (“Appili”), a biopharmaceutical company focused on developing innovative treatments and vaccines to combat some of the most challenging infectious diseases and potential bioterrorism threats. Read More
Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics
Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics
Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics
Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics
Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute